Projekt

PH-L19IL2TNFNMSC-04/19 A phase II study of intratumoral administration of L19IL2/L19TNF in non-melanoma skin cancer patients with presence of injectable lesions

Laufend - Rekrutierung – laufend · 2020 bis 2030